Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents

ClinicalTrials.gov ID: NCT02140762

Public ClinicalTrials.gov record NCT02140762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Controlled, Observer-Blind, Multi-Center Study Assessing the Effectiveness, Immunogenicity and Safety of Novartis Meningococcal ABCWY Vaccine Administered to Healthy Adolescents in the U.S.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Evaluate the effectiveness of 2 doses of MenABCWY vaccine in adolescents compared to a single dose of MenACWY vaccine.

Study identification

NCT ID
NCT02140762
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Vaccines
Industry
Enrollment
305 participants

Conditions and interventions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
10 Years to 18 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2014 (Type not available)
Primary completion
Nov 2014 (Actual)
Completion
Feb 2015 (Actual)
Last update posted
Sep 12, 2018

2014 – 2015

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Accelovance, Inc Huntsville Alabama 35802 —
The Children's Clinic of Jonesboro, P.A. Jonesboro Arkansas 72401 —
Accelovance, Inc Melbourne Florida 32935 —
Heartland Research Associates LLC Newton Kansas 67114 —
Heartland Research Associates, LLC Wichita Kansas 67207 —
Bluegrass Clinical Research, Inc. Louisville Kentucky 40291 —
Meridian Clinical Research Omaha Nebraska 68134 —
Senders Pediatrics Cleveland Ohio 44121 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02140762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 12, 2018 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02140762 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →